• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Anaplastic Plasmacytoma

Anaplastic Plasmacytoma - 139 Studies Found

Terminated : Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2005-09-26
:
  • Dietary Supplement: ascorbic acid
  • Drug: ar

Withdrawn : Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma
:
  • Stage I Multiple Myeloma
  • Stage II Multiple Myeloma
  • Stage I
    : 2005-06-02
    :
    • Drug: arsenic trioxide
    • Drug: ascorbic acid

Withdrawn : Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
:
  • Stage II Multiple Myeloma
  • Stage III Multiple Myeloma
  • Refra
    : 2004-06-10
    :
    • Drug: arsenic trioxide
    • Drug: ascorbic acid

Completed : Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2004-06-10
: Drug: bortezomib
Completed : S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma
:
  • Multiple Myeloma
  • Plasma Cell Neoplasm

: 2003-07-08
:
  • Drug: dexamethasone Given oral

Completed : Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2003-05-06
: Drug: brostallicin Patients receive brostallicin IV over 1
Completed : Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2003-02-05
:
  • Drug: dexamethasone
  • Drug: doxorubicin hydr

Completed : Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2002-11-12
:
  • Drug: prednisone Given orally

Completed : Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2002-11-12
:
  • Biological: oblimersen sodium
  • Drug: dexame

Completed : Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
:
  • Infection
  • Multiple Myeloma and Plasma Cell Neoplasm

: 2002-10-03
:
  • Biological: filgrastim
  • Biological: pneumoc

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.